Evommune, Inc. Common Stock (EVMN)

Capital Expenditure

-$501.00K

TTM · Period ending: · USD

EVMN logo

EVMN Capital Expenditure

Latest reported-$501.00K
EVMN CapEx (-$118.00K → -$501.00K)
High-resolution chart · PNG

EVMN capital expenditure history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Evommune, Inc. Common Stock Capital Expenditure — Annual fiscal periods (USD)
Period endingCapital Expenditure (USD)
-235,000
-88,000
-118,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.